LADENBURG THALM/SH SH Begins Coverage on Calidi Biotherapeutics (NYSEAMERICAN:CLDI)
LADENBURG THALM/SH SH assumed coverage on shares of Calidi Biotherapeutics (NYSEAMERICAN:CLDI – Free Report) in a research report report published on Thursday morning, MarketBeat reports. The brokerage issued a buy rating and a $1.00 target price on the stock. Several other brokerages have also recently issued reports on CLDI. Robert W. Baird dropped their target […]
More Stories
LogiTron (LTR) Price Reaches $0.0005 on Top Exchanges
LogiTron (LTR) traded flat against the U.S. dollar during the one day period ending at 0:00 AM Eastern on July...
Shentu Price Reaches $0.70 on Major Exchanges (CTK)
Shentu (CTK) traded 2.2% lower against the US dollar during the 1-day period ending at 0:00 AM E.T. on July...
Lego Coin (LEGO) Self Reported Market Capitalization Tops $9,000.00 Billion
Lego Coin (LEGO) traded flat against the US dollar during the one day period ending at 0:00 AM Eastern on...
Ponke Tops 24 Hour Trading Volume of $31.75 Million (PONKE)
Ponke (PONKE) traded 0.8% lower against the dollar during the 24 hour period ending at 0:00 AM Eastern on July...
Populous Price Hits $0.0333 (PPT)
Populous (PPT) traded 6.7% lower against the U.S. dollar during the 24 hour period ending at 0:00 AM Eastern on...
Saxon Interests Inc. Reduces Stock Position in JPMorgan International Bond Opportunities ETF (BATS:JPIB)
Saxon Interests Inc. reduced its holdings in shares of JPMorgan International Bond Opportunities ETF (BATS:JPIB – Free Report) by 56.6%...